Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06631313 · ClinicalTrials.gov registry record · NA

PureWick™ Adolescent Study

A NA study, sponsored by C. R. Bard.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT06631313 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 43 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06631313, a NA study, has completed, sponsored by C. R. Bard.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

A prospective, uncontrolled, open-label healthy volunteer study to assess the performance of the PureWick Male and PureWick Flex Female external catheter devices in adolescents

Interventions

  • DEVICE PureWick System

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2024-08-28
Est. Completion 2024-09-25
Phase NA

Sponsor

C. R. Bard

75 total trials

What the Registry Record Tells You About NCT06631313

The ClinicalTrials.gov registry entry for NCT06631313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PureWick System is the first listed.

NCT06631313 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06631313 about?

NCT06631313 is a clinical study titled "PureWick™ Adolescent Study". A prospective, uncontrolled, open-label healthy volunteer study to assess the performance of the PureWick Male and PureWick Flex Female external catheter devices in adolescents

What is the current status of trial NCT06631313?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2024-08-28. Estimated completion is 2024-09-25.

What interventions are being tested in trial NCT06631313?

The interventions under investigation include: PureWick System (DEVICE).

Who is sponsoring clinical trial NCT06631313?

This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.